- Home
- SVRE vs NURO Comparison
SVRE vs NURO Comparison
Compare SVRE & NURO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRE
- NURO
- Stock Information
- Founded
- SVRE 2014
- NURO 1996
- Country
- SVRE Israel
- NURO United States
- Employees
- SVRE N/A
- NURO N/A
- Industry
- SVRE
- NURO Medical/Dental Instruments
- Sector
- SVRE
- NURO Health Care
- Exchange
- SVRE Nasdaq
- NURO Nasdaq
- Market Cap
- SVRE 2.6M
- NURO 8.2M
- IPO Year
- SVRE 2022
- NURO N/A
- Fundamental
- Price
- SVRE $0.12
- NURO $4.42
- Analyst Decision
- SVRE
- NURO
- Analyst Count
- SVRE 0
- NURO 0
- Target Price
- SVRE N/A
- NURO N/A
- AVG Volume (30 Days)
- SVRE 5.3M
- NURO 14.4K
- Earning Date
- SVRE 08-27-2024
- NURO 11-01-2024
- Dividend Yield
- SVRE N/A
- NURO N/A
- EPS Growth
- SVRE N/A
- NURO N/A
- EPS
- SVRE N/A
- NURO N/A
- Revenue
- SVRE $458,952.00
- NURO $4,383,614.00
- Revenue This Year
- SVRE N/A
- NURO N/A
- Revenue Next Year
- SVRE $422.52
- NURO N/A
- P/E Ratio
- SVRE N/A
- NURO N/A
- Revenue Growth
- SVRE N/A
- NURO N/A
- 52 Week Low
- SVRE $0.11
- NURO $2.66
- 52 Week High
- SVRE $1.50
- NURO $5.60
- Technical
- Relative Strength Index (RSI)
- SVRE 29.85
- NURO 65.06
- Support Level
- SVRE $0.11
- NURO $3.96
- Resistance Level
- SVRE $0.13
- NURO $4.69
- Average True Range (ATR)
- SVRE 0.01
- NURO 0.22
- MACD
- SVRE 0.00
- NURO 0.04
- Stochastic Oscillator
- SVRE 24.14
- NURO 82.35
About SVRE SaverOne 2014 Ltd.
Saverone 2014 Ltd provides driver protection solutions. The company develops and deploys ADAS technologies for transportation safety and driver assistance. The company's product restricts the driver from surfing, communicating, and receiving alerts while driving. The Company has developed a system that provides a solution to the problem of distracted driving caused by cell phone use, which endangers the driver, passengers, other drivers on the road, and pedestrians.
About NURO NeuroMetrix Inc.
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.